Overview

Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of the present study was to examine the influence of memantine, a noncompetitive NMDA receptor blocker, in depression co-morbid with long term alcohol heavy use comparing to SSRI-inhibitor, escitalopram. Second goal is to compare their influence to cognitive tasks and the third goal is to follow up alcohol-use with these two medicines.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Finnish Institute for Health and Welfare
National Institute for Health and Welfare, Finland
Collaborator:
Finnish Foundation for Alcohol Studies
Treatments:
Citalopram
Dexetimide
Memantine
Criteria
Inclusion Criteria:

1. The subject/patient is able to read and understand the subject/patient information
sheet.

2. Prior to any screening procedures, the subject/patient must have signed the informed
consent form. No study-related procedures may be performed before the subject/patient
has signed the form.

3. Age 25-70 years

4. Heavy alcohol consumption (males more than 5 doses/ day, female more than 4 doses/day)
for at least 10 years

5. Alcohol dependence (DSM-IV) assessed by SCID-I interview.

6. Major depression (DSM-IV) assessed by SCID-I interview. At least 4 weeks past from the
previous inpatient treatment for AWS (alcohol withdrawal syndrome).

Exclusion Criteria:

1. Other drug dependence (screened by urine test)

2. Other serious mental illness (DSM-IV)

3. Hazard of suicide

4. Pregnancy

5. Serious kidney, hart or thyroid problem

6. The subject/patient, in the opinion of the investigator, is unlikely to comply with
the clinical study protocol or is unsuitable for any reason.

7. Liver cirrhosis or liver enzymes ASAT tai ALAT >200.

8. The person that met the criteria stated in the Finnish Law on Clinical Studies,
paragraph 7-10ยง (children, pregnant, imamates or mentally handicapped).